Amsterdam UMC - Amsterdam Neuroscience

🎤 And we’re off! We are incredibly excited to start the Amsterdam Neuroscience Annual Meeting 2024. Kicking off the morning are our directors, Guus Smit, Yolande Pijnenburg and Marten Smidt. Next, prof. dr. Marjo van der Knaap and her team will give a comprehensive overview of the field of leukodystrophies, and the incredible developments we have seen in 35 years of research. Afterwards, speakers from Young Amsterdam Neuroscience will take the stage. We can’t wait to see what the day has in store for us. Curious about the programme? Check it out here: https://lnkd.in/eepd5AbX . . . Marc Engelen Niek P. van Til Nicole Wolf Yvo Roos Priyanka Rao-Ruiz Nienke de Wit Henk(-Jan) Mutsaerts Anke Dijkstra Max Koppers Anouk Schrantee Joram Mul Amsterdam UMC Vrije Universiteit Amsterdam Universiteit van Amsterdam Swammerdam Institute for Life Sciences (SILS), University of Amsterdam #neuroscience #annualmeeting #leukodystrophy #research #science #neurology

🙌 Congratulations to Associate Professor and senior scientist at Amsterdam Neuroscience and Amsterdam UMC - Alzheimercentrum Amsterdam Betty Tijms! She has been awarded the European Research Council (ERC) – Consolidator Grant. With nearly 3 million euros in funding, she will investigate whether the five biological variants of Alzheimer’s disease, that she previously discovered, respond differently to medication.

We are excited to say that the Amsterdam Neuroscience Annual Meeting 2024 is only two weeks away! Join us at RAI Amsterdam on December 13 for a day filled with exciting lectures, showcases by Young Amsterdam Neuroscientists, and updates on revolutionary cases in neuroscience. All neuroscientists and -clinicians of Amsterdam UMC, Vrije Universiteit Amsterdam and Universiteit van Amsterdam are invited to attend! Don’t miss your chance to connect with your peers and fellow neuroscientists - if you haven’t yet done so, sign up here! ➡️ https://lnkd.in/eepd5AbX Yolande Pijnenburg Guus Smit Marten Smidt Marjo van der Knaap Niek P. van Til Nicole Wolf Nienke de Wit Henk(-Jan) Mutsaerts Anke Dijkstra Max Koppers Anouk Schrantee Joram Mul Priyanka Rao-Ruiz Lars Van Der Heide Ingo Willuhn Madeleine Oudin #neuroscience #meeting #research

✨ 𝐄𝐞𝐧 𝐛𝐢𝐣𝐳𝐨𝐧𝐝𝐞𝐫𝐞 𝐝𝐚𝐠 𝐯𝐨𝐨𝐫 𝐝𝐞𝐦𝐞𝐧𝐭𝐢𝐞𝐨𝐧𝐝𝐞𝐫𝐳𝐨𝐞𝐤!   Afgelopen vrijdag vond de Dutch Dementia Researchers Conference plaats, georganiseerd door ZonMw, Alzheimer Nederland, DEMPACT en Health~Holland. Deze inspirerende ééndaagse conferentie bood een prachtige kans om onderzoek te delen en collega-dementieonderzoekers te ontmoeten. 🧠💡   Onze collega Jolande Zijlstra gaf samen met Wiesje van der Flier (#ABOARD) en Pieter van Bokhoven (Amsterdam UMC) een inspirerende sessie over publiek-private samenwerking met aandacht voor valorisatie. Tijdens deze sessie deelden zij inzichten en ervaringen over hoe samenwerking tussen publieke en private partijen kan bijdragen aan innovatieve doorbraken in het onderzoek naar dementie.   En wat een timing! Een dag eerder werd bekendgemaakt dat Het Europees Geneesmiddelenbureau (European Medicines Agency) het medicijn Lecanemab heeft goedgekeurd voor toelating op de Europese markt. Een historisch moment: voor het eerst is er een medicijn beschikbaar dat de ziekte van Alzheimer kan afremmen. Dit is niet alleen een mijlpaal voor het onderzoek, maar ook een lichtpuntje voor patiënten en hun naasten. 🌟

This #WorldStrokeDay, we are excited to share that a large international study led by Amsterdam UMC supports new treatment for cerebral venous thrombosis (CVT), a rare type of stroke. The recently revealed results suggest that patients with CVT can be safely and efficaciously treated with direct oral anticoagulants (DOACs). This finding has important implications for patient management. “In general, DOACs are more patient friendly, as they do not require dose adjustments based on plasma concentrations. They also have a lower risk of intracranial hemorrhage,” says Jonathan Coutinho, stroke neurologist and lead researcher. Read more ➡️ https://lnkd.in/eutxn_xd Amsterdam Cardiovascular Sciences #WorldStrokeDay #stroke #CVT #research #science

Dr. Amélie Fréal, assistant professor at Amsterdam UMC and researcher at the Cellular & Molecular Mechanisms research programme at Amsterdam Neuroscience, has received a Vidi grant of 850.000 euros from the Dutch Research Council (NWO). Congratulations, Amélie! The Vidi grant is aimed at postdoc researchers with academic qualities that clearly exceed what is customary and who are transitioning to leadership. With this grant, Amélie will be able to continue her research on understanding the mechanisms controlling the composition of the axon initial segment. Read more ➡️ https://lnkd.in/ewzMQ-hy NWO (Nederlandse Organisatie voor Wetenschappelijk Onderzoek) #grant #research #neuroscience

Grab your last chance to benefit from the early bird registration for the International Lewy Body Dementia Conference (ILBDC), which will take place January 2025 in our beautiful Amsterdam! Early bird registration ends October 31st. Register here: https://lnkd.in/eBzyZ537  . . . Evelien Lemstra Juliette van Alphen Dédé Handgraaf Camar Bohnen Dag Aarsland Per Borghammer Alessandra Fanciulli MD PhD Philip Scheltens Tanya Simuni Amanda Woerman Lahdy Lauvenberg Partners in Congress Organisation - PCO Amsterdam UMC Amsterdam UMC - Amsterdam Neuroscience #ILBDC #LewyBody #LewyBodyDementia #conference #dementia #dementie #science #wetenschap #earlybird

💊 The existing HIV drug Efavirenz may also be effective for patients with Alzheimer's disease. The clinical trial to test this will start this fall at Amsterdam UMC. The research is led by researcher Rik van der Kant and neurologist Everard (Jort) Vijverberg from Amsterdam UMC - Alzheimercentrum Amsterdam. Van der Kant discovered that an accumulation of cholesterol in the brain cells of Alzheimer's patients directly leads to an accumulation of the toxic proteins Tau and Amyloid. The drug Efavirenz turned out to be suitable for reversing this accumulation. “You don't believe it at first, but all subsequent tests showed the same result,” says Van der Kant. Vijverberg is also hopeful. “It remains a matter of first seeing and then believing, but I see it as a promising step in the right direction.” The trial is still looking for participants. In total, forty patients with early-stage Alzheimer's are needed to participate in the clinical trial, which will last three months. Read more ⬇️ https://lnkd.in/e2UWXDuC 

A number of vacancies have opened up within the Amsterdam Neuroscience network! Check them out ⬇️ Help medicine breach the blood-brain barrier in cancer and Alzheimer patients, or expand research on stroke treatment using endovascular thrombectomy (EVT). Or contribute to life-saving treatments in an entirely different way, by implementing suicide prevention methods in the SAVE-project. With groundbreaking research in both mental and physical health, there is truly something for everyone. Find the latest information about all vacancies on our website (make sure to scroll down!): https://lnkd.in/ddkH84j7 #vacancies #neuroscience #phd #postdoc #research

Max Koppers was awarded a Starting Grant from the European Research Council (ERC)! With this, Max will expand his research group to further investigate how specific mRNAs are captured at specific subcellular locations in neurons. Congratulations, Max! Read more about the grant and Max’s research here: https://lnkd.in/eFkEXY4c